Question 1

What is ALISKIREN HEMIFUMARATE used for?

Accepted Answer

ALISKIREN HEMIFUMARATE (brand name Tekturna) is a Other indicated for 1 INDICATIONS AND USAGE Tekturna is a renin inhibitor (RI) indicated for the treatment of hypertension in adults and in pediatric patients weighing 50 kg or greater who are at least 6 years of age, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, including.

Question 2

How does ALISKIREN HEMIFUMARATE work?

Accepted Answer

ALISKIREN HEMIFUMARATE works through the following mechanism: 12.1 Mechanism of Action Renin is secreted by the kidney in response to decreases in blood volume and renal perfusion. Renin cleaves angiotensinogen to form the inactive decapeptide angiotensin I (Ang I). Ang I is converted to the active octapeptide angiotensin II (Ang II) by ACE and non-ACE pathways. Ang II is a powerful vasoconstrictor and leads to the release of catecholamines from the adrenal medulla and prejunctional nerve endings. It also promotes aldosterone secretion and sodium reabsorption. Together, these effects increase blood pressure. Ang II also inhibits renin release, thus providing a negative feedback to the system. This cycle, from renin through angiotensin to aldosterone and its associated negative feedback loop, is known as the renin-angiotensin-aldosterone system (RAAS). Aliskiren is a direct renin inhibitor, decreasing plasma renin activity (PRA) and inhibiting the conversion of angiotensinogen to Ang I. Whether aliskiren affects other RAAS components, e.g., ACE or.

Question 3

What are the most common side effects of ALISKIREN HEMIFUMARATE?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for ALISKIREN HEMIFUMARATE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is ALISKIREN HEMIFUMARATE the same as Tekturna?

Accepted Answer

Tekturna is a brand name for ALISKIREN HEMIFUMARATE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

ALISKIREN HEMIFUMARATE

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations